QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Congress quietly expands farm-industry procurement mandates, opens USDA to private funding

S. 2654 — Biomanufacturing and Jobs Act of 2025 · Filed by Elissa Slotkin (D-MI) · 3 cosponsors · Introduced Aug 1, 2025 · Referred to committee

65%
Transparency
Typical bill: 82%
28/100
Hidden-provision risk
Typical bill: 15/100
Agricultural Commodity Market Support

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill expands the USDA's BioPreferred Program, which promotes biobased products made from agricultural commodities like corn and soybeans. It requires federal agencies to increase purchases of biobased products annually, establishes a task force to coordinate USDA biobased research and marketing, creates labeling standards to prevent misuse of terms like 'biobased plastic,' and allows the USDA to accept private funding for public marketing campaigns. The bill benefits farmers and rural economies by creating new markets for agricultural feedstock, and benefits biomanufacturers by mandating federal procurement and public promotion.

Why we flagged it

The bill's core function is to expand federal procurement of biobased products and create marketing infrastructure to support agricultural feedstock markets. While framed as rural economic development and energy independence, it is fundamentally a market-creation mechanism for a specific agricultural sector.

What the text implies

  • Private funding for USDA marketing campaigns (via the 'contributions account') may create conflicts of interest: biomanufacturers and agricultural interests could fund USDA promotion of their own products, blurring the line between government advocacy and industry lobbying.
  • Federal procurement mandates with 'price premium' provisions may lock taxpayers into above-market costs for biobased products, with no sunset clause or cost-benefit review mechanism.

The full analysis lists 5 implications of this text.

Who stands to gain

agricultural commodity producers (corn, soybean farmers); biomanufacturers and biobased product companies; companies producing biobased plastics and industrial materials

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record